Exact Sciences Corporation
EXAS | NASDAQ
$104.91
$0.00 (0.00%)
At close: Mar 20, 2026, 4:00 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | 3.25B | 2.76B | 2.5B | 2.08B | 1.77B | 1.49B |
Cost of Revenue | 984.15M | 840.2M | 737.6M | 661.36M | 458.76M | 354.3M |
Gross Profit | 2.26B | 1.92B | 1.76B | 1.42B | 1.31B | 1.14B |
Operating Income | -99.08M | -1.05B | -215.01M | -593.51M | -855.68M | -767.7M |
Interest Income | 42.75M | n/a | n/a | n/a | n/a | 6.57M |
Pretax Income | -203.89M | -1.04B | -201.75M | -632.57M | -842.51M | -829.06M |
Net Income | -207.95M | -1.03B | -204.15M | -623.51M | -595.63M | -823.61M |
Selling & General & Admin | 1.94B | 1.67B | 1.62B | 1.59B | 1.66B | 1.07B |
Research & Development | 523M | 431.21M | 426.93M | 394.19M | 385.65M | 554.05M |
Other Expenses | -99.94M | 868.06M | -70.05M | 29.21M | 115.21M | 279.42M |
Operating Expenses | 2.36B | 2.97B | 1.98B | 2.02B | 2.16B | 1.9B |
Interest Expense | 32.87M | 31.97M | 24.42M | 13.91M | 12.88M | 17.12M |
Selling & Marketing Expenses | 1.05B | 247.5M | 225.7M | 929.64M | 861.89M | 589.92M |
Cost & Expenses | 3.35B | 3.81B | 2.71B | 2.68B | 2.62B | 2.26B |
Income Tax Expense | 4.06M | -7.3M | 2.4M | -9.06M | -246.88M | -5.46M |
Shares Outstanding (Basic) | 188.69M | 184.2M | 180.14M | 176.35M | 171.35M | 151.14M |
Shares Outstanding (Diluted) | 188.69M | 184.2M | 180.14M | 176.35M | 171.35M | 151.14M |
EPS (Basic) | -1.10 | -5.59 | -1.13 | -3.54 | -3.48 | -5.45 |
EPS (Diluted) | -1.10 | -5.59 | -1.13 | -3.54 | -3.48 | -5.45 |
EBITDA | 50.56M | -789.33M | 29.28M | -421.11M | -649.28M | -653.88M |
EBIT | -171.02M | -1B | -177.33M | -618.66M | -829.63M | -817.24M |
Depreciation & Amortization | 221.58M | 214.86M | 206.61M | 197.56M | 180.35M | 163.36M |
Add to Watchlist
Select watchlists to add or remove EXAS